Stock price falls after wider-than-expected loss
- SI-BONE shares drop 14% following 4Q loss
- Shares down 14% to $17.60
- Stock has declined 17% since the beginning of the year
- Fourth-quarter loss of $11 million
- Revenue rose 22% to $38.9 million
Shares of SI-BONE dropped 14% following the company’s fourth-quarter loss. The stock price is currently at $17.60, down 17% since the beginning of the year. SI-BONE reported a loss of $11 million in the fourth quarter, compared to a loss of $11.2 million in the same period last year. However, revenue increased by 22% to $38.9 million, surpassing analysts’ expectations.
Factuality Level: 8
Factuality Justification: The article provides specific details about SI-BONE’s financial performance, including the company’s fourth-quarter loss, revenue, and stock price movement. The information is sourced from FactSet, which adds credibility to the report. There are no obvious signs of bias, sensationalism, or inaccuracies in the article.
Noise Level: 3
Noise Justification: The article provides relevant information about SI-BONE’s financial performance, including details about the company’s quarterly loss, revenue, and stock price movement. It stays on topic and supports its claims with data and examples. However, it lacks in-depth analysis, accountability, and actionable insights, which prevents it from scoring higher.
Financial Relevance: Yes
Financial Markets Impacted: Shares of SI-BONE
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Rating Justification: The article pertains to financial topics as it discusses the financial performance of SI-BONE, a medical device company. However, there is no mention of any extreme event or its impact.
Public Companies: SI-BONE (N/A)
Key People: Sabela Ojea (N/A)
www.marketwatch.com 
